Kymera Therapeutics, Inc. rStock RKYMR
RKYMR
0
$
0.00 %
Change 24h
Market Cap
$ 0
Total Supply
0
RKYMR
$
| # | Exchange | Pair | Price | Volume 24h |
|---|
Description
Clinical-stage biopharmaceutical company developing novel small molecule protein degraders for oncology and immunology.